The forecast for liver malignant neoplasms mortality among females in Japan reveals a consistent decline from 2024 to 2028, with values decreasing from 7.74 thousand in 2024 to 6.96 thousand in 2028. Comparing the changes between each forecasted year, the year-on-year decrease shows a steady rate of decline. Analyzing the compound annual growth rate (CAGR) over these five years, the data indicate a consistent reduction in the mortality rate, reflecting advancements in healthcare interventions or improved lifestyle preventative measures. As of 2023, the value was slightly higher than 7.74 thousand, highlighting this downward trend.
Future trends to watch include the impact of emerging medical technologies and treatments, increased public health campaigns, and potential changes in environmental factors or policies that may further influence mortality rates. Monitoring these factors can provide valuable insights into how the landscape of healthcare and disease prevention is evolving in Japan.
